Zimmer Biomet Transformation Off to Strong Start in 2026 Company Revenue The Numbers The company grew in the high-single digits during the first quarter of 2026 as it transitions its U.S. sales force. Apr 29, 2026
State of the Trauma Market 2026 Market Analysis The Numbers A look at the state of the trauma market, including 2025 player performance and three market trends that will drive future growth. Apr 23, 2026
What We’re Watching: 2026 First Quarter Earnings Results Videos A new video covering VB Spine's growing technology arsenal, new battlegrounds for market share and Zimmer Biomet's outlook. Apr 20, 2026
DePuy Synthes Completes Operationally Solid First Quarter Company Revenue The Numbers The company grew in the mid-single-digits on a reported basis for the first quarter of 2026 ahead of its impending separation from J&J. Apr 15, 2026
ATEC Set to Join Orthopedics’ Top-Tier Companies Chart of the Month Our chart of the month looks at ATEC's incredible sales growth from 2017 to the company's 2026 year-end guide. Apr 13, 2026
Checking In on Orthofix Medical’s Trauma Business Chart of the Month The Numbers Our chart of the month looks at Orthofix's trauma sales as the company strategically focuses on limb reconstruction in the U.S. market. Mar 10, 2026
Smith+Nephew Ends 2025 With Best Quarter in Two Years Company Revenue The Numbers The company grew in the mid-single digits in 2025 on the strength of its new products and continuing adoption of the CORI robot. Mar 05, 2026
Orthopedic Executives Reflect on Fourth Quarter of 2025 Executive Insights Industry Voices Selected comments from the leaders of top orthopedic companies as they reported fourth quarter 2025 earnings. Mar 02, 2026
Orthofix Driving Substantial Growth Through Top Distributors Company Revenue The Numbers The company grew in the low-single-digits in 2025 as it transitions its distributors and strategically shifts to earnout placements for 7D. Feb 27, 2026
Carlsmed Shows Promise in Reducing Spine Reoperation Rates Company Revenue The Numbers In 2025, the company nearly doubled its prior year sales while significantly reducing lead times and expanding its indications. Feb 27, 2026